Syed Raza|S Raza, Syed I.Raza, SI. Raza

Syed Raza|S Raza, Syed I.Raza, SI. Raza

Amicus Therapeutics - Philadelphia / United States
Others
AD Scientific Index ID: 5691186
person_outline Syed Raza|S Raza, Syed I.Raza, SI. Raza's MOST POPULAR ARTICLES
1-) Prescribing in type 2 diabetes patients with and without cardiovascular disease history: a descriptive analysis in the UK CPRD Clinical Therapeutics 43 (2), 320-335, 2021
2-) Long-term cost-effectiveness analyses of empagliflozin versus oral semaglutide, in addition to metformin, for the treatment of type 2 diabetes in the UK Diabetes Therapy 11, 2041-2055, 2020
3-) Quality of Life with Late-Onset Pompe Disease: Qualitative Interviews and General Public Utility Estimation in the United Kingdom Journal of Health Economics and Outcome Research 10 (1), 2023
4-) Differential Appraisal of Functional Outcome Measures by Health Technology Assessment (HTA) Agencies When Reviewing Therapies for Rare Muscular, Skeletal and Neurodegenerative … Value in Health 25 (1), S175, 2022
5-) Comparing the efficacy of cipaglucosidase alfa plus miglustat with other enzyme replacement therapies for late-onset Pompe disease: a network meta-analysis utilizing patient … Journal of Comparative Effectiveness Research 13 (10), e240045, 2024